Graham Capital Management, L.P.

Position in IONS — Ionis Pharmaceuticals Inc

CIK 1315421 ROWAYTON, CT

Position in IONS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,325,490

+$724,571 QoQ

Shares Held

16,717

+120.1% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#223

of 504 holders

Holding Since

Dec 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Graham Capital Management, L.P. holds $44,243,780 across 71 Biotechnology names. IONS ranks #3 (3.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TVTX	Travere Therapeutics, Inc.	446,696	$25,376,799
2	INCY	Incyte Corp	15,632	$1,772,043
3	IONS	Ionis Pharmaceuticals Inc This page	16,717	$1,325,490
4	VKTX	Viking Therapeutics, Inc.	22,114	$862,667
5	ALNY	Alnylam Pharmaceuticals, Inc.	2,256	$679,123
6	ARVN	Arvinas, Inc.	81,364	$676,134
7	PCVX	Vaxcyte, Inc.	11,107	$645,649
8	MRVI	Maravai Lifesciences Holdings, Inc.	92,277	$575,808

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,325,490	16,717	+120.1%	Shares	Sole	2026-08-14
2025-12-31	$600,919	7,596	-55.7%	Shares	Sole	2026-02-17
2025-09-30	$1,122,803	17,163	-18.0%	Shares	Sole	2025-11-14
2025-06-30	$827,141	20,935	-31.5%	Shares	Sole	2025-08-14
2024-03-31	$1,323,952	30,541	+143.8%	Shares	Sole	2024-05-15
2023-12-31	$633,639	12,525	-13.5%	Shares	Sole	2024-02-14
2023-09-30	$657,175	14,488	-73.0%	Shares	Sole	2023-11-22
2022-09-30	$2,375,902	53,717	-12.0%	Shares	Sole	2022-11-14
2022-06-30	$2,258,701	61,013	+203.5%	Shares	Sole	2022-08-15
2022-03-31	$744,504	20,100	+195.4%	Shares	Sole	2022-05-16
2021-12-31	$207,045	6,804	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.